MAQUET Cardiovascular announced that it has received both 510(k) clearance from the FDA and CE mark from the EMEA for its new SENSATION PLUS™ 8 Fr. 50cc intra-aortic balloon catheter (IAB). The new SENATION PLUS is the world’s first 8 Fr. IAB catheter to combine fiber optic signal acquisition with greater hemodynamic support compared to a standard 40cc IAB catheter. This combination of fiber optic technology and greater hemodynamic support represents a new standard of care with respect to intra-aortic counterpulsation therapy. In addition to these features, the SENSATION PLUS IAB catheter offers faster initiation of therapy, easier patient management and a crisp, clean arterial pressure wave form.
For more information, visit www.maquet.com.